Current antiarrhythmic drugs for AF have limited ... and atrial remodeling. Class III drugs sotalol, dofetilide and ibutilide target reentry by prolonging the atrial effective refractory period ...
However, the efficacy of antiarrhythmic agents has not been rigorously evaluated in patients with ARVC, and limited data are available to support such use of these drugs. The Multidisciplinary ...
Antiarrhythmic drugs (AADs) are often used after ablation for atrial fibrillation (AF); the drugs employed vary, but most common are the drugs that were unsuccessful prior to ablation since it ...
Lignocaine is a class IB antiarrhythmic drug and is the first choice for VT. It is given intravenously in a dose of 1–3 mg/kg. For cardiac arrest, a 100 mg bolus is given, which may be repeated after ...